MLD-S2-M2: Identification of Pre-Symptomatic Patients - The Importance of Family Screening

	EIP is delighted to announce a NEW free-to-access webinar on Spotting the Signs of Metachromatic Leukodystrophy (MLD)

	MLD-S2-M2: Identification of Pre-Symptomatic Patients - The Importance of Family Screening

	4 May 2022
	The webinar is now organised. Register to access the video.

	COURSE DESCRIPTION
	Metachromatic Leukodystrophy (MLD) is a rare hereditary disease characterized by the accumulation of fats called sulfatides. This causes the destruction of the protective fatty layer (myelin sheath) surrounding the nerves in both the central nervous system and the peripheral nervous system, ultimately affecting intellectual and motor function. Early-onset clinical manifestations are often overlooked or confused with other conditions causing confusion among non-trained HCPs at first contact, resulting in misdiagnosis, wrong referral routes and delays in the early start of treatment. Delays in starting treatment have significant consequences on the conditions’ development, and the patient’s health and quality of life. This delay in referral and treatment must be overcome.

	Language: English* ● Duration: 30 minutes followed by questions from the audience*

	Presenter: Federica Deodato, Bambino Gesù Hospital, Rome, Italy

	TARGET AUDIENCE
	This educational activity is designed for an international audience of General Pediatricians, General Practitioners, Pediatric Neurologists and other physicians and healthcare professionals with an interest in Metabolic Diseases and Genetics.



	LEARNING OBJECTIVES
	✓ Providing an overview of MLD in children

	✓ Exploring the onset of symptoms and diagnostic delays - looking for the clues for early diagnosis

	✓ Reviewing new therapies that may change the natural history

	✓ Examining a Case Study example on MLD

	✓ Understanding the importance of early detection, the early start of treatment and sibling screening for MLD



	Click below to start your free registration

Take the opportunity to visit all EIP websites and learn about the activities of the Excellence in Pediatrics Institute, the annual Excellence in Pediatrics Conference offering cross-speciality education, the Excellence in Pediatrics Community of pediatricians allowing members to engage in peer-to-peer learning through webinars and online courses, Vaccines Together an online collaboration hub, targeting to increase vaccination coverage rates, and the Education Programs Spot the Early Signs of MPS and Spot the Early Signs of MLD aiming to fight under-diagnosed or late-diagnosed conditions for which early diagnosis can make a difference.



Business Days: Monday to Friday Business Hours: 9:00 - 18:00 Central European Time Contact Phone: +41 43 21 55 937 Email: [email protected] Address: Rue des Vignerons 1B, c/o H&B Law, 1110 Morges 1 (VD), Switzerland Copyright © 2022 Excellence in Pediatrics. All Rights Reserved.

MLD-S2-M2: Identification of Pre-Symptomatic Patients - The Importance of Family Screening

MLD-S2-M2: Identification of Pre-Symptomatic Patients - The Importance of Family Screening

4 May 2022

The webinar is now organised. Register to access the video.

COURSE DESCRIPTION

TARGET AUDIENCE

LEARNING OBJECTIVES

Click below to start your free registration